| technology, pharmaceutical | The application of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures and in the treatment of patients. (12 Dec 1998) |
|---|
| chemistry, pharmaceutical | Chemistry that deals with the composition and preparation of substances used in treatment of patients or diagnostic studies. (12 Dec 1998) |
|---|---|
| pharmaceutical | 1. Pertaining to pharmacy or to drugs. 2. <pharmacology> A medicinal drug. (18 Nov 1997) |
| pharmaceutical biology | <pharmacology, study> A subfield of pharmacology which studies natural drugs, including the study of their biological and chemical components, botanical sources, and other characteristics (economic, biochemical, biological, etc.). (09 Oct 1997) |
| pharmaceutical chemistry | Medicinal chemistry in its application to the analysis, development, preparation, and the manufacture of drugs. Synonym: medicinal chemistry, pharmacochemistry. (05 Mar 2000) |
| pharmaceutical preparations | Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. (12 Dec 1998) |
| pharmaceutical services | Total pharmaceutical services provided by a qualified pharmacist. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist. (12 Dec 1998) |
| pharmaceutical solutions | Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products. (12 Dec 1998) |
| preservatives, pharmaceutical | Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include antibiotics and antioxidants. (12 Dec 1998) |
| societies, pharmaceutical | Societies whose membership is limited to pharmacists. (12 Dec 1998) |
| insurance, pharmaceutical services | Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products. (12 Dec 1998) |
| economics, pharmaceutical | Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (12 Dec 1998) |
| fees, pharmaceutical | Amounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc. (12 Dec 1998) |
| antibody technology | <molecular biology> Techniques for the synthesis of polyclonal and monoclonal antibodies for use in research, diagnostics and therapeutics. (09 Feb 1998) |
| assisted reproductive technology | Originally, a range of techniques for manipulating eggs and sperm in order to overcome infertility. Encompasses drug treatments to stimulate ovulation; surgical methods for removing eggs (e.g., laparoscopy and ultrasound-guided transvaginal aspiration) and for reimplanting embryos (e.g., zygot intrafallopian transfer (or ZIFT); in vitro and in vivo fertilization (e.g., artificial insemination and gamete intrafallopian transfer (or GIFT); ex utero and in utero foetal surgery; as well as laboratory regimes for freezing and screening sperm and embryos, and micromanipulating and cloning embryos. The field's first major success came in 1978 with the birth of "test-tube baby" Louise Brown, engineered by Steptoe, Edwards, et al., of England. As the technologies spread, they increasingly are being employed for purposes beyond infertility, i.e., to reduce the risk of, or avoid passing on, hereditary disease and to select for infant sex. Further uses that would aim at improving the "quality" of offspring have been widely discussed and raise profound legal and ethical questions. See: eugenics. (05 Mar 2000) |
| recombinant DNA technology | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |